The Era of Immuno-Oncology: Are We There Yet?

被引：0
|
作者：
Villasboas, Jose C. [1 ]
Ansell, Stephen M. [1 ]
机构：
[1] Mayo Clin, Dept Med, Div Hematol, Rochester, MN 55905 USA
来源：
ONCOLOGY-NEW YORK | 2015年 / 29卷 / 03期
关键词：
RITUXIMAB;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：204 / 205
页数：2
相关论文
共 50 条
  • [31] Microbiome, Cancer, and Immuno-oncology
    Yamada, Takuji
    Yachida, Shinichi
    CANCER SCIENCE, 2021, 112 : 167 - 167
  • [32] Biotech and Breakthroughs in Immuno-Oncology
    Bockman, Jeffrey M.
    UROLOGIC CLINICS OF NORTH AMERICA, 2020, 47 (04) : 511 - 521
  • [33] An Immuno-Oncology Primer for Physicists
    Ford, Eric
    Chang, Sha
    Schoenfeld, J.
    Jin, J.
    MEDICAL PHYSICS, 2020, 47 (06) : E349 - E350
  • [34] Immuno-oncology for Gynecologic Malignancies
    How, Jeffrey
    Patel, Ami
    Jazaeri, Amir
    IMMUNOTHERAPY, 3RD EDITION, 2020, 1244 : 149 - 182
  • [35] Immuno-oncology in the daily practice
    Laparra, Ariane
    CURRENT OPINION IN ONCOLOGY, 2025, 37 (02) : 136 - 141
  • [36] Introduction: Immuno-oncology seminar
    Sabel, Michael S.
    Brady, Mary S.
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (03) : 708 - 709
  • [37] New developments in immuno-oncology
    Ochsenreither, S.
    ONKOLOGE, 2021, 27 (11): : 1114 - 1119
  • [38] Designing nanomedicine for immuno-oncology
    Jiang, Wen
    von Roemeling, Christina A.
    Chen, Yuanxin
    Qie, Yaqing
    Liu, Xiujie
    Chen, Jianzhu
    Kim, Betty Y. S.
    NATURE BIOMEDICAL ENGINEERING, 2017, 1 (02):
  • [39] Immuno-oncology checkpoint inhibitors
    不详
    NATURE BIOTECHNOLOGY, 2022, 40 (07) : 1005 - 1005
  • [40] The adenosine pathway in immuno-oncology
    Allard, Bertrand
    Allard, David
    Buisseret, Laurence
    Stagg, John
    NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (10) : 611 - 629
12345